Decontamination of N95 Masks During the COVID-19 Pandemic
Penn State University sought ways to safely decontaminate N95 respirators for reuse in response to the COVID-19 pandemic. They thoroughly tested CURIS System's ability to decontaminate against three (3) viruses including SARS-CoV-2, Herpes Simplex Virus 1 (HSV-1), and Coxsackie Virus B3 (CVB3), and two (2) bacteria, including Pseudomonas and Geobacillus Stearothermophilus. Without fail, CURIS' easy-to-use system and protocols successfully killed all tested germs. Additionally, it was proven that all treated respirators remained fully functional. This study is published on MedRxiv.org. In partnership with Pathogo LLC.
Request this study
Decontamination of a Room, its Contents, and HEPA Filter
Simultaneous decontamination of a laboratory and a biological safety cabinet.
Until now, this type of decontamination has required at least two separate processes enlisting multiple technologies at high costs for equipment and personnel, not to mention treatment time. This study with The Baker Company investigated the efficacy of the CURIS System in the decontamination of a laboratory and a biological safety cabinet using just one device and one treatment. In partnership with Pathogo LLC.
Request this study
National Institute of Health (NIH) Investigated the CURIS System Ability to Penetrate Biofilm
Effective reduction of biofilm with Pulse Hybrid-Hydrogen Peroxide.
Biofilm is a hot topic in the decontamination world for good reason. Even chemicals that can kill germs often have a hard time penetrating through contaminants to get to the target pathogens. Skin oils, chemical residues, detritus, grime, and other bodily fluids layer onto surfaces, making a protective cover and/or reservoir for dangerous germs.
In this study done with the U.S. National Institutes of Health (NIH), CURIS System proves its ability to substantially reduce active cultures even in the presence of biofilm.
Effective in wet and dry biofilm.Request this study
Containing an Outbreak at the Ground Level: 100% Decrease of Norovirus in a 1600 Bed Assisted Living Facility
Knowing how a product will perform in a real-world scenario is vital.
An Erickson Living facility learned the efficacy of CURIS System in conjunction with a properly trained service company. This study discusses and examines the successful use of CURIS System and protocols to contain and stop an outbreak of Norovirus in a 1600-bed facility in a very short amount of time. In partnership with Pathogend of New Jersey.Request this study
Eliminating C. diff in a Tri-Part Soil Load
CURIS System is proud to lead the way by meeting the EPA’s most recent and stringent C. diff efficacy requirements; the ability to kill C. diff in a tri-part soil load. This accomplishment sets us apart from others and cements our commitment to efficacy, health, and safety.Request this study
Alleviating Bio-Burden in a Wound Care Center
Real-world disinfection often brings greater challenges than faced in standard testing. That is why CURIS System encourages everyone to validate the efficacy of their treatments. In this study, CURIS measures pre- and post- treatment levels of bio-burden to prove its ability to protect against dangerous pathogens. By combining our superior devices with custom treatment plans, CURIS successfully enabled wound care facility managers to significantly reduce the risks of HAI in their facility.Request this study
EMS Documented Results of CURIS System
Request this study
Since emergency response personnel never know the full extent of potential pathogens they may encounter, creating an environment free of biological contaminates is crucial as a staging point and finish to patient care in order to help protect them and their next patient. The Children’s Hospital of Atlanta and Dougherty County EMS in Georgia, partnered with Pathogend of Georgia, a bio-decontamination services company, to perform treatments using CURIS System and collect data in an effort to ensure maximum disinfection possible. The results of this study clearly show a significant and measurable improvement in the ambulance environment following treatment with the CURIS® 7% Hybrid Hydrogen Peroxide™ system.
Feasibility and Efficacy of Daily Disinfection Practices in MASS Transit During the COVID-19 Pandemic
Communities depend on public transportation for access to jobs, schools, healthcare, and basic necessities. In response to the COVID-19 pandemic, transportation providers needed to improve disinfection efforts in order to protect the health of staff and riders alike. This study looks at the feasibility of implementing large-scale, daily disinfection of each bus in a fleet, the impact on the fleet, effectiveness, sustainability, and methods employed for validation, preventing staff exposure to pathogens or chemicals. Using CURIS System and specific protocols, a mass transit organization successfully executed over 100,000 disinfection treatments over a course of less than 7 months.Request this study